Jonas Leichsenring

Coburg, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies.

Evaluating Claudin-6 and isochromosome 12p in the progression from germ cell neoplasia in situ to primary testicular germ cell tumor and post-chemotherapy teratoma: implications for CLDN6-targeted therapies.

Journal: Therapeutic advances in medical oncology

Published: October 06, 2025

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.

High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.

Journal: Journal of ovarian research

Published: March 23, 2023

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

Journal: Frontiers in immunology

Published: November 11, 2022

Title Not Found

Title Not Found

Journal: Der Pathologe

Published: October 04, 2021

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy.

Journal: BMC cancer

Published: June 14, 2021

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine.

Journal: Genes, chromosomes & cancer

Published: May 22, 2021

Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.

Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma.

Journal: Translational lung cancer research

Published: May 20, 2021

Variant interpretation in molecular pathology and oncology : An introduction

Variant interpretation in molecular pathology and oncology : An introduction

Journal: Der Pathologe

Published: March 25, 2021

Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.

Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 10, 2020

Integrating proteomics into precision oncology.

Integrating proteomics into precision oncology.

Journal: International journal of cancer

Published: June 29, 2020

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary.

Journal: International journal of cancer

Published: October 31, 2019

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 04, 2019

Showing 1-12 of 48

Last Updated: 09/26/2026